These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 436537)

  • 1. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
    Forester D
    Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
    [No Abstract]   [Full Text] [Related]  

  • 2. Lidocaine in Wolff-Parkinson-White syndrome with atrial fibrillation.
    Josephson ME; Kastor JA; Kitchen JG
    Ann Intern Med; 1976 Jan; 84(1):44-5. PubMed ID: 1244791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
    Bennett DH
    Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
    Prystowsky EN
    Herz; 1983 Jun; 8(3):133-43. PubMed ID: 6135656
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of cardiac arrhythmias.
    Robinson SJ
    Pediatr Clin North Am; 1964 May; 11(2):315-62. PubMed ID: 4174540
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome.
    Sellers TD; Campbell RW; Bashore TM; Gallagher JJ
    Circulation; 1977 Jan; 55(1):15-22. PubMed ID: 830205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jun; 89(6):804-8. PubMed ID: 1130271
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.
    Meltzer RS; Robert EW; McMorrow M; Martin RP
    Am J Cardiol; 1978 Dec; 42(6):1049-53. PubMed ID: 727132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contraindications to the use of digitalis in atrial fibrillation in the course of Wolff-Parkinson-White syndrome].
    Bracchetti D; Binetti G; D'Osualdo F; Magnani B
    Boll Soc Ital Cardiol; 1974; 19(2):181-6. PubMed ID: 4462802
    [No Abstract]   [Full Text] [Related]  

  • 11. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
    Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
    Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
    Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention.
    Tonkin AM; Gallagher JJ; Wallace AG
    JAMA; 1976 Mar; 235(9):947-9. PubMed ID: 946127
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of ventricular tachycardia in an infant.
    Sanchez J; Christie K; Cumming GR
    Can Med Assoc J; 1972 Jul; 107(2):136-8. PubMed ID: 5041936
    [No Abstract]   [Full Text] [Related]  

  • 15. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
    Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ
    Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disopyramide.
    Morady F; Scheinman MM; Desai J
    Ann Intern Med; 1982 Mar; 96(3):337-43. PubMed ID: 7036817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical studies of Norpace (Part X).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):148. PubMed ID: 46728
    [No Abstract]   [Full Text] [Related]  

  • 18. Three therapeutic approaches in tachycardia.
    Preston TA; Yates JD; Brymer JF
    Geriatrics; 1973 Mar; 28(3):110-6. PubMed ID: 4691599
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular fibrillation in Wolff-Parkinson-White syndrome, type A.
    Papa LA; Saia JA; Chung EK
    Heart Lung; 1978; 7(6):1015-9. PubMed ID: 251167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of atrial fibrillation in patients with Wolff-Parkinson-White syndrome using ajmaline and quinidine].
    García Civera R; Sanjuán Mañez R; Rodríguez Serra M; García-Sacritán J; Morell Cabedo S; Llavador Sanchis J
    Rev Esp Cardiol; 1982; 35(3):277-84. PubMed ID: 7134591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.